JUV-161

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameJUV-161
Drug Alias NameJUV161JUV-161
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyotonic DystrophyMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJuvena Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJuvena Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic DystrophyMuscular Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A